Company Filing History:
1 out of 185 
1 out of 19 Years Active: 2008
Title: A Look into the Innovations of Kouichirou Hagihara
Introduction
Kouichirou Hagihara, based in Iruma-gun, Japan, is an accomplished inventor recognized for his significant contributions to the field of medicinal chemistry. With a focus on synthesizing novel compounds, Hagihara has made notable strides in addressing various health issues through his innovative inventions.
Latest Patents
Hagihara holds a patent for "4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same, and medicinal use of the same." This patent introduces novel 4-(2-furoyl)aminopiperidines, characterized by their potential medicinal applications. These compounds are particularly noteworthy for their opioid μ antagonistic activity, which can be beneficial in treating side effects caused by μ receptor agonists, including constipation, nausea/emesis, and itch. Additionally, they have applications in the treatment or prevention of idiopathic constipation, postoperative ileus, paralytic ileus, irritable bowel syndrome, and chronic pruritus.
Career Highlights
Throughout his career, Kouichirou Hagihara has been associated with esteemed organizations, such as Kyorin Pharmaceutical Co., Ltd. and Nisshin Pharma Inc. His experiences at these companies have enabled him to develop and refine his research and development skills in pharmaceutical sciences, contributing to the advancement of innovative medical therapies.
Collaborations
Hagihara has collaborated with fellow researchers, including Ryuuta Fukutomi and Hitoshi Inoue. These partnerships have played a crucial role in the successful development of his patented inventions, demonstrating the importance of teamwork in the research and innovation process.
Conclusion
Kouichirou Hagihara’s contributions to the medicinal chemistry field, particularly through his innovative patents, underscore the vital role of inventors in the healthcare industry. His work not only exemplifies the spirit of innovation but also addresses pressing medical challenges, paving the way for improved therapeutic options for patients worldwide.